Comparison of Fatty Acid Contents of Erythrocyte Membrane in Hemodialysis and Peritoneal Dialysis Patients

Journal of Renal Nutrition

Volumn 19, Issue 4, 2009, Pages 267-274

  An, W S ^a   Kim, S E ^a   Kim, K H ^a   Lee, S ^b   Park, Y ^c   Kim, H J ^d   Vaziri, N D ^d  

^a Dong A University   (South Korea)

^b Pusan National University   (South Korea)

^c Hanyang University   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

AGED; ARTICLE; BLOOD; CHEMISTRY; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET; DIET SUPPLEMENTATION; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY;

AGED; ARACHIDONIC ACID; CROSS-SECTIONAL STUDIES; DIET; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS;

EID: 66949111736     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2009.01.027     Document Type: Article

References (22)

1. Foley R.N. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 16 (2003) 111-117
2. Keith D.S., Nichols G.A., Gullion C.M., et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
3. GISSI-Prevenzione Investigators. Dietary supplementation with omega-3 polyunsaturated fatty acids and vitamin E in 11,324 patients with myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
4. Kang J.X., Xiao Y.F., and Leaf A. Free long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 92 (1995) 3997-4001
5. Leaf A. The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: heart and brain. Lipids 36 suppl (2001) S107-S110
6. Leaf A., Kang J.X., Xiao Y.F., et al. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107 (2003) 2646-2652
7. Harris W.S., Sands S.A., Windsor S.L., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 21 (2004) 1645-1649
8. Dasgupta A., Kenny M.A., and Ahmad S. Abnormal fatty acid profile in chronic hemodialysis patients: Possible deficiency of essential fatty acids. Clin Physiol Biochem 8 (1990) 238-243
9. Peck L.W., Monsen E.R., and Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am J Clin Nutr 64 (1996) 210-214
10. Varga Z., Karpati I., Paragh G., Buris L., et al. Relative abundance of some free fatty acids in plasma of uremic patients: relationship between fatty acids, lipid parameters, and diseases. Nephron 77 (1997) 417-421
11. Koorts A.M., Viljoen M., and Kruger M.C. Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment. Prostaglandins Leukot Essent Fatty Acids 67 (2002) 13-18
12. Friedman A.N., Moe S.M., Perkins S.M., et al. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis 47 (2006) 1064-1071
13. Kromhout D. N-3 fatty acids and coronary heart disease: epidemiology from Eskimos to Western populations. J Intern Med Suppl 731 (1989) 47-51
14. Koorts A.M., Viljoen M., and Kruger M.C. Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment. Prostaglandins Leukot Essent Fatty Acids 67 (2002) 13-18
15. Harris W.S., and Von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 39 (2004) 212-220
16. DeFillipis A.P., and Sperling L.A. Understanding omega-3's. Am Heart J 151 (2006) 564-570
17. Egan B.M., Lu G., and Greene E.L. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostaglandins Leukot Essent Fatty Acids 60 (1999) 411-420
18. Lu G., Greene E.L., Nagai T., et al. Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 32 (1998) 1003-1011
19. Nestel P., Clifton P., and Noakes M. Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res 35 (1994) 656-662
20. Sarabi M., Vessby B., Millgard J., and Lind L. Endothelium-dependent vasodilation is related to the fatty acid composition of serum lipids in healthy subjects. Atherosclerosis 156 (2001) 349-355
21. Saifullah A., Watkins B.A., Saha C., et al. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients: a pilot study. Nephrol Dial Transplant 22 (2007) 3561-3567
22. Burns T., Maciejewski S.R., Hamilton W.R., et al. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio. Pharmacotherapy 27 (2007) 633-638